 |
|
recombinant interleukin-4
A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine interleukin-4 (IL-4). Produced primarily by activated T-cells, IL-4 binds to and activates its cell-surface receptor, stimulating the proliferation and differentiation of activated B-cells and enhancing their ability to present antigens to T-cells. As a potential immunotherapeutic agent, recombinant IL-4 also augments the effects of other cytokines on dendritic cells (DC), cytotoxic T lymphocytes (CTL), and tumor-infiltrating lymphocytes (TIL). Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | B Cell Proliferating Factor
B-Cell Growth Factor
B-Cell Stimulating Factor
B-Cell Stimulatory Factor 1
Mast Cell Growth Factor-2
recombinant human IL-4
T-Cell Growth Factor 2 | | | | Abbreviations: | | BCGF
BCSF 1
IL-4
MCGF 2
rhIL-4 | | |
| Previous: | recombinant interleukin-1-beta, recombinant interleukin-11, recombinant interleukin-12, recombinant interleukin-18, recombinant interleukin-3 | | Next: | recombinant interleukin-6, recombinant interleukin-7, recombinant macrophage colony-stimulating factor, recombinant MAGE-3.1 antigen, recombinant MAGE-A3 antigen-specific cancer immunotherapeutic GSK1203486A |
|
|
